Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on: May 27,2024

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on:May 27,2024

Researchers find protein promotes cancer, suppresses anti-tumor immunity

by University of Texas M. D. Anderson Cancer CenterKiller T cells surround a cancer cell. Credit: NIHResearchers at The University of Texas MD Anderson Cancer Center have found that a protein inv

Updated on: June 24,2024

Researchers find protein promotes cancer, suppresses anti-tumor immunity

by University of Texas M. D. Anderson Cancer CenterKiller T cells surround a cancer cell. Credit: NIHResearchers at The University of Texas MD Anderson Cancer Center have found that a protein inv

Updated on:June 24,2024

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on: January 08,2024

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on:January 08,2024

Map of tumors' immune cell populations points to new targets for immunotherapy

by Kevin Jiang,Harvard Medical SchoolMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteThe recent emergence of immuno

Updated on: April 09,2024

Map of tumors' immune cell populations points to new targets for immunotherapy

by Kevin Jiang,Harvard Medical SchoolMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteThe recent emergence of immuno

Updated on:April 09,2024

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people

Updated on: March 09,2024

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people

Updated on:March 09,2024

Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on: January 22,2024

Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on:January 22,2024

New therapeutic opportunity for the treatment of resistant malignant melanoma

by University de LiegeMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A team of researchers led by Dr. Pierre Clos

Updated on: April 10,2024

New therapeutic opportunity for the treatment of resistant malignant melanoma

by University de LiegeMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A team of researchers led by Dr. Pierre Clos

Updated on:April 10,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on: March 30,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on:March 30,2024

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules

Updated on: January 22,2024

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules

Updated on:January 22,2024

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h

Updated on: February 03,2024

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h

Updated on:February 03,2024

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,

Updated on: April 01,2024

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,

Updated on:April 01,2024

Designing an emergency stop switch for immunotherapies

by Ecole Polytechnique Federale de LausanneA mollecule allows for 'switching off' the therapy when a cancer patient's life is in danger. Credit: EPFLImmunotherapy, unlike chemotherapy

Updated on: March 09,2024

Designing an emergency stop switch for immunotherapies

by Ecole Polytechnique Federale de LausanneA mollecule allows for 'switching off' the therapy when a cancer patient's life is in danger. Credit: EPFLImmunotherapy, unlike chemotherapy

Updated on:March 09,2024